REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,000 | -10.0% | 13,304 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $10,000 | -86.5% | 13,304 | -81.2% | 0.01% | -87.5% |
| Q4 2017 | $74,000 | +45.1% | 70,804 | +73.5% | 0.04% | +33.3% |
| Q3 2017 | $51,000 | -5.6% | 40,804 | +70.7% | 0.03% | -11.8% |
| Q4 2016 | $54,000 | -63.8% | 23,904 | -47.1% | 0.03% | -64.2% |
| Q3 2016 | $149,000 | -27.0% | 45,204 | -36.1% | 0.10% | -28.0% |
| Q2 2016 | $204,000 | -35.0% | 70,704 | +56.1% | 0.13% | -37.1% |
| Q1 2016 | $314,000 | +17.2% | 45,300 | +47.5% | 0.21% | +22.1% |
| Q4 2015 | $268,000 | -8.8% | 30,713 | -31.7% | 0.17% | -16.1% |
| Q3 2015 | $294,000 | +32.4% | 45,000 | +122.1% | 0.20% | +53.0% |
| Q2 2015 | $222,000 | -35.3% | 20,260 | 0.0% | 0.13% | -36.2% |
| Q1 2015 | $343,000 | – | 20,260 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $943,000 | 0.99% |
| DAFNA Capital Management LLC | 421,500 | $1,218,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 350,000 | $1,012,000 | 0.18% |
| BOURGEON CAPITAL MANAGEMENT LLC | 70,704 | $204,000 | 0.13% |
| Piermont Capital Management Inc. | 151,924 | $439,000 | 0.11% |
| Virtus ETF Advisers LLC | 46,269 | $134,000 | 0.10% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 389,144 | $1,124,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 80,637 | $233,000 | 0.06% |
| South Dakota Investment Council | 900,000 | $2,601,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 33,100 | $96,000 | 0.05% |